Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry. We have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question.
-
Industry
-
Biotechnology Research
-
Company size
-
51-200 employees
-
Headquarters
-
Cambridge, Massachusetts
-
Type
-
Privately Held
-
Founded
-
2016
-
Specialties
-
Biotechnology, Discovery Science, DNA Sequencing, DNA Synthesis, CRISPR, Bioengineering, Computer Science, Molecular Biology, Machine Learning, Biochemistry, Protein Biology, and Gene Editing